US Stock MarketDetailed Quotes
ASND Ascendis Pharma A/S
- 134.600
- +3.750+2.87%
Close Nov 26 16:00 ET
- 134.600
- 0.0000.00%
Post 16:01 ET
8.04BMarket Cap-17192P/E (TTM)
134.710High128.630Low508.13KVolume131.420Open130.850Pre Close67.83MTurnover0.86%Turnover RatioLossP/E (Static)59.76MShares161.00052wk High-78.76P/B7.98BFloat Cap101.43052wk Low--Dividend TTM59.32MShs Float183.980Historical High--Div YieldTTM4.65%Amplitude11.920Historical Low133.487Avg Price1Lot Size
About Ascendis Pharma A/S Company
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.
Company Profile
SymbolASND
Company NameAscendis Pharma A/S
Listing DateJan 28, 2015
Issue Price18.00
Founded2006
CEOMr. Jan Moller Mikkelsen
MarketNASDAQ
Employees879
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressTuborg Boulevard 12
CityHellerup
ProvinceCapital Region
CountryDenmark
Zip Code2900
Phone45-70-22-22-44
Company Executives
- Name
- Position
- Salary
- Jan Moller Mikkelsen
- President, Chief Executive Officer and Director
- --
- Michael Wolff Jensen
- Executive Vice President and Chief Legal Officer
- --
- Camilla Harder Hartvig
- Executive Vice President and Global Chief Commercial Officer
- --
- Scott T Smith
- Executive Vice President and Chief Financial Officer
- --
- Lotte Sonderbjerg
- Executive Vice President and Chief Administrative Officer
- --
- Peter Rasmussen
- Vice President, Finance and Principal Accounting Officer
- --
- Flemming Steen Jensen
- Executive Vice President, Product Supply and Quality
- --
- Dr. Stina Singel, M.D.
- Executive Vice President and Head of Clinical Development, Oncology
- --
- Dr. Kennett Sprogoe, PhD
- Executive Vice President and Head of Innovation and Research
- --
- Dr. Albert Cha, M.D.,PhD
- Chairman of the Board
- --
- Siham Imani
- Independent Director
- --
- William Carl Fairey
- Independent Director
- --
- Lisa Bright
- Independent Director
- --
- Lars Holtug
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data